Compared with other ablative therapies, stereotactic body radiotherapy might offer a ‘particularly advantageous option’ for ...

vs SBRT alone in patients with metachronous oligorecurrent hormone-sensitive prostate cancer (HSPC). 1 The data were published in Lancet Oncology. In total, the study enrolled 105 patients who were ...

A short course of androgen deprivation therapy (ADT) added to stereotactic body radiotherapy (SBRT) halved the risk of ...

Metastatic breast cancer is complex, requiring holistic care and ongoing treatment, with varying prognosis depending on ...

Phase 2 data support the use of SBRT in patients with CRPC who have 1-5 metastatic sites, according to researchers.

SBRT provided better local tumor control, while both treatments were effective and well-tolerated. SBRT improved local progression-free survival over RFA in small recurrent HCC, particularly in tumors ...

Objective: This systematic review aimed to evaluate the impact of sublobar resection (SLR) on the quality of life (QoL) of patients with early-stage non-small cell lung cancer (NSCLC). Specifically, ...

Since the existence of the oligometastatic disease state was posited three decades ago,1 there has been interest in ...

The SBRT arm had significantly prolonged radiographic progression-free survival (rPFS) compared with patients who received enzalutamide plus ADT alone: 4.6 vs 2.3 years, for a significant 52% ...

or stereotactic body radiation therapy (SBRT) may be a promising strategy. Here, we presented a case of a refractory metastatic gastric adenocarcinoma patient with pMMR who received a notable response ...